# A Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calmette-Guerin Therapy for High-risk Non-muscle Invasive Bladder Cancer.

> **NCT07268339** · PHASE3 · NOT_YET_RECRUITING · sponsor: **The Christie NHS Foundation Trust** · enrollment: 328 (estimated)

## Conditions studied

- High-Risk Non-Muscle Invasive Bladder Cancer

## Interventions

- **RADIATION:** radiotherapy
- **OTHER:** BCG

## Key facts

- **NCT ID:** NCT07268339
- **Lead sponsor:** The Christie NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2031-12-01
- **Final completion:** 2031-12-01
- **Target enrollment:** 328 (ESTIMATED)
- **Last updated:** 2025-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07268339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07268339, "A Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calmette-Guerin Therapy for High-risk Non-muscle Invasive Bladder Cancer.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07268339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*